Rémi Rabasa-Lhoret, MD, PhD
IRCM · Montreal Clinical Research Institute · Institut de Recherches Cliniques de Montreal
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Rémi Rabasa-Lhoret, MD, PhD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:21 UTC. Open this list on ClinicalTrials.gov
- N/ANCT06158503 · Glycemic Control and Osteohealth in Adults Living With Type 1 DiabetesCentre hospitalier de l'Université de Montréal (CHUM) · recruiting · Type 1 Diabetes · principal investigator
- N/ANCT05626725 · Safety and Effectiveness of Automated Insulin Delivery (AID) Systems in Physically Active Adults With Type 1 DiabetesInstitut de Recherches Cliniques de Montreal · completed · Type 1 Diabetes · principal investigator
- N/ANCT04496921 · Vitamin K Supplementation to Reduce Deficiencies in Adults With Cystic FibrosisInstitut de Recherches Cliniques de Montreal · withdrawn · Cystic Fibrosis · principal investigator
- N/ANCT04385862 · The Use of a Continuous Glucose Monitoring System (Dexcom G6) in Hospitalized Patients for Acute CareCentre hospitalier de l'Université de Montréal (CHUM) · withdrawn · Continuous Glucose Monitoring · principal investigator
- N/ANCT03710538 · The Effect of a Pre-meal Snack and/or Exercise on Post-prandial Glycemic Excursions in Adults With Cystic FibrosisInstitut de Recherches Cliniques de Montreal · completed · Cystic Fibrosis · principal investigator
- N/ANCT03227094 · Simplification of CF-related Diabetes Screening at HomeInstitut de Recherches Cliniques de Montreal · completed · Cystic Fibrosis, Cystic Fibrosis-related Diabetes · principal investigator
- N/ANCT02810691 · The Effect of Soluble Fiber to Reduce Post-prandial Glycemic Excursion in Adults With Cystic FibrosisInstitut de Recherches Cliniques de Montreal · completed · Cystic Fibrosis-related Diabetes, Cystic Fibrosis · principal investigator
- Ph2NCT02488616 · Closed-loop Control of Glucose Levels (Artificial Pancreas) for 5 Days in Adults With Type 1 DiabetesInstitut de Recherches Cliniques de Montreal · withdrawn · Type 1 Diabetes · principal investigator
- N/ANCT02485132 · Evaluating the True Magnitude of HYPOglycemic Events After THE Initiation of SulfonylureaInstitut de Recherches Cliniques de Montreal · terminated · Type 2 Diabetes · principal investigator
- Ph2NCT02189694 · Closed-loop Control of Overnight Glucose Levels (Artificial Pancreas) in Children With Type 1 Diabetes in a Diabetes CampInstitut de Recherches Cliniques de Montreal · completed · Type 1 Diabetes · principal investigator
- Ph2NCT01966393 · Closed-loop Control of Glucose Levels (Artificial Pancreas) for 60 Hours in Adults With Type 1 DiabetesInstitut de Recherches Cliniques de Montreal · completed · Type 1 Diabetes · principal investigator
- Ph2NCT01930097 · Closed-loop Control of Glucose Levels After Meal Intake in Adults With Type 1 DiabetesInstitut de Recherches Cliniques de Montreal · completed · Type 1 Diabetes · principal investigator
- Ph2NCT01930110 · Closed-loop Control of Glucose Levels (Artificial Pancreas) During Exercise in Adults With Type 1 DiabetesInstitut de Recherches Cliniques de Montreal · completed · Type 1 Diabetes · principal investigator
- Ph2NCT01905020 · Closed-loop Control of Overnight Glucose Levels in Adults and Adolescents With Type 1 DiabetesInstitut de Recherches Cliniques de Montreal · completed · Type 1 Diabetes · principal investigator
- Ph2NCT01754337 · Closed-loop Control of Glucose Levels (Artificial Pancreas) for 24 Hours in Adults and Adolescents With Type 1 DiabetesInstitut de Recherches Cliniques de Montreal · completed · Type 1 Diabetes · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 12:21 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.